|
PSIMCT-1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.053900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.448400E-02 |
| Normal-vs-Stage2 |
7.939600E-01 |
| Normal-vs-Stage3 |
3.932400E-02 |
| Normal-vs-Stage4 |
7.497000E-03 |
| Stage1-vs-Stage2 |
3.201000E-01 |
| Stage1-vs-Stage3 |
6.236200E-01 |
| Stage1-vs-Stage4 |
1.327620E-01 |
| Stage2-vs-Stage3 |
1.979600E-01 |
| Stage2-vs-Stage4 |
6.750200E-02 |
| Stage3-vs-Stage4 |
3.643800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.477610E-02 |
| Normal-vs-AfricanAmerican |
5.405900E-02 |
| Normal-vs-Asian |
1.651440E-01 |
| Caucasian-vs-AfricanAmerican |
7.772800E-01 |
| Caucasian-vs-Asian |
6.161900E-02 |
| AfricanAmerican-vs-Asian |
4.769500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.984050E-02 |
| Normal-vs-Female |
8.572200E-02 |
| Male-vs-Female |
6.498000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.025400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.863700E-02 |
| Normal-vs-Age(61-80Yrs) |
6.583600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.588800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.316400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.476600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.123800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.267400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.382400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.214400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.103800E-01 |
| Normal-vs-Grade 2 |
9.927500E-02 |
| Normal-vs-Grade 3 |
1.055820E-02 |
| Normal-vs-Grade 4 |
5.001700E-02 |
| Grade 1-vs-Grade 2 |
1.645420E-01 |
| Grade 1-vs-Grade 3 |
4.634200E-02 |
| Grade 1-vs-Grade 4 |
1.192630E-01 |
| Grade 2-vs-Grade 3 |
1.785840E-01 |
| Grade 2-vs-Grade 4 |
3.403600E-01 |
| Grade 3-vs-Grade 4 |
9.606000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.508170E-01 |
| Normal-vs-ccB subtype |
7.234100E-02 |
| ccA subtype-vs-ccB subtype |
6.339200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.508400E-02 |
| Normal-vs-N1 |
9.451600E-01 |
| N0-vs-N1 |
5.970600E-01 |
|
|
